Description:
Application(s):
Flow Cytometry (cell permeabilization required)
Immunocytochemistry (cytospin preparations)
Immunohistochemistry (frozen sections, paraffin sections).
Recommended starting dilution is 1:20. Optimal conditions should be determined individually for each application.
POSITIVE CONTROL:
Cell lines: Appropriate drug-sensitive parental cell lines and their multdrug resistant derivatives prepared by the same methods as the test specimens should be used as control materials.
Tissue: Human colon, kidney, bronchus or adrenal are recommended.
|
| Type | Isotype | Clone | Grade |
|---|
| Mab | IgG2b | 6D537 | Supernatant |
|
| Size | | Storage | Shipping | Source | Host |
|---|
| 50ug | | -20°C | Blue Ice | Human | Mouse |
|
| Concentration: |
| ~0.25mg/ml |
| Immunogen: |
| Human MVP/LRP (major vault protein / lung resistance protein). |
| Purity: |
| Supernatant |
| Form |
| Liquid. Antibody in serum free culture supernatant containing 0.7% BSA and 0.1% sodium azide. |
| Specificity: |
| Recognizes an internal epitope (P110) of human MVP/LRP, which is overexpressed in various human non-P-glycoprotein MDR tumor cell lines. |
|
| Intended for research use only. Not for use in human, therapeutic, or diagnostic applications. |
1. R.J. Scheper, et al. (1993) Cancer Res. 53:1475. 2. D. Schadendorf, et al. (1995) Am. J. Pathol. 147:1545. 3. M.J. Flens, et al. (1997) Int. J. Cancer 73:249. 4. A.B. Schroeijers, et al. (1998) Am. J. Pathol. 152:3735. 5. D. Mayr, et al. (2000) Pathol. Res. Pract. 196:469. 6. A.B. Schroeijers, et al. (2000) Cancer Res. 60:1104. 7. A.B. Schroeijers, et al. (2001) J. Histochem. Cytochem. 49:1379. 8. A. Van Zon, et al. (2003) J. Cell Sci. 116:4391.
|
|
